Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Aug 16, 2011
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
In this study we investigate whether milk based protein sources of BCAA (casein and whey proteins) are superior to soy protein in the stimulation of protein anabolism before, during and after cycle exercise in COPD and healthy elderly and young subjects, and whether adding BCAA to soy protein will increase protein anabolism in these subjects.
To investigate Leucine, Isoleucine and Valine metabolism during and after exercise in COPD and healthy subjects
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Irreversible chronic airflow limitation (FEV1 \<70% of predicted)
- • Clinically stable condition
- Exclusion Criteria:
- • Oxygen supplementation
- • Respiratory tract infection or exacerbation of his disease at least 4 weeks prior to the study
- • Oral corticosteroids as maintenance medication
- • Other concomitant metabolic disease (ie malignancy, cardiac failure, recent surgery, severe endocrine, hepatic or renal disorder)
Trial Officials
Nicolaas EP Deutz, MD, PhD
Principal Investigator
University of Arkansas
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials